4-11399162-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005114.4(HS3ST1):c.844C>T(p.Leu282Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000483 in 1,614,084 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005114.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HS3ST1 | NM_005114.4 | c.844C>T | p.Leu282Phe | missense_variant | 2/2 | ENST00000002596.6 | NP_005105.1 | |
HS3ST1 | XM_011513913.4 | c.844C>T | p.Leu282Phe | missense_variant | 2/2 | XP_011512215.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HS3ST1 | ENST00000002596.6 | c.844C>T | p.Leu282Phe | missense_variant | 2/2 | 1 | NM_005114.4 | ENSP00000002596 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000143 AC: 36AN: 251380Hom.: 1 AF XY: 0.000206 AC XY: 28AN XY: 135914
GnomAD4 exome AF: 0.0000451 AC: 66AN: 1461880Hom.: 1 Cov.: 30 AF XY: 0.0000550 AC XY: 40AN XY: 727240
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152204Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2022 | The c.844C>T (p.L282F) alteration is located in exon 2 (coding exon 1) of the HS3ST1 gene. This alteration results from a C to T substitution at nucleotide position 844, causing the leucine (L) at amino acid position 282 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at